Release Date: 07/10/19 16:34 Summary: Becoming a substantial holder from IFL Price Sensitive: No Download Document 58.19KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%